GlucoTrack amends 8-K to update terms of $900,000 note-for-shares exchange agreement

GlucoTrack filed an amended Form 8-K to correct its disclosure of an Exchange Agreement, replacing a July 22 version with a July 24 agreement.

The revised deal partitions a $900,000 promissory note from an existing note, leaving the remaining balance outstanding under prior terms.

The investor can exchange the partitioned note into common stock at a "Minimum Price" tied to recent Nasdaq closing prices, with share delivery due by Aug. 31, 2026.

Issuance is capped by a 9.99% beneficial ownership limit, which could require multiple tranches and leave some of the note outstanding.